Joint VentureMay 28, 2026, 06:46 AM
Suzano gets antitrust approvals for Kimberly-Clark JV
AI Summary
Suzano S.A. announced that it has received all necessary antitrust regulatory approvals for its acquisition of a 51% equity interest in a new company from Kimberly-Clark Corporation. This new company will hold assets related to the manufacturing and sale of tissue products across South America, Central America, Europe, Africa, the Middle East, Asia, and Oceania. The closing of the transaction is still contingent on Kimberly-Clark's corporate reorganization in these regions, with completion expected in the third quarter of 2026.
Key Highlights
- Suzano obtained all antitrust regulatory approvals for its joint venture with Kimberly-Clark.
- The transaction involves Suzano acquiring a 51% equity interest in a new company.
- Kimberly-Clark will hold the remaining 49% of the Target Company.
- The Target Company will manage tissue product assets in South America, Central America, Europe, Africa, Middle East, Asia, and Oceania.
- Closing remains subject to Kimberly-Cark's corporate reorganization in the included regions.
- The transaction is still expected to close in the third quarter of 2026.
- Kimberly-Clark will retain its 'family care' and 'professional business' assets in North America.
Price Impact
More from SUZ